• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MAO-B 抑制剂 (2E)-3-(4-溴苯基)-1-(1H-吲哚-3-基)丙-2-烯-1-酮作为一种治疗阿尔茨海默病的神经保护剂。

MAO-B Inhibitor (2E)-3-(4-Bromophenyl)-1-(1H-indol-3-yl) prop-2-en-1-one as a Neuroprotective Agent Against Alzheimer's Disease.

机构信息

College of Pharmaceutical Sciences, Government Medical College, Thiruvananthapuram, Kerala, 695011, India.

Department of Biochemistry, St. Thomas College, Pala, Kottayam, Kerala, 686574, India.

出版信息

Neurochem Res. 2024 Jun;49(6):1518-1528. doi: 10.1007/s11064-023-04031-6. Epub 2023 Oct 9.

DOI:10.1007/s11064-023-04031-6
PMID:37814132
Abstract

Chalcones (trans-1,3-diphenyl-2-propen-1-ones) form simple chemical structures that act as precursors for the biogenesis of flavonoids. These are distributed in plants and have two aromatic or heteroaromatic rings connected by a three-carbon α, β-unsaturated carbonyl group. Considering the importance of chalcones as monoamine oxidase and acetylcholinesterase inhibitors, the study was designed as a comprehensive and systematic analysis to evaluate the pharmacological activities leading to the formation of drug molecules against Alzheimer's disease (AD). Based on our previous research, 11 indolyl chalcones (IC1-IC11) were synthesised and investigated for MAO-B inhibitory activity. The inhibitory potential was evaluated based on binding and reversibility studies using purified enzymes. The active and most promising molecule, (2E)-3-(4-bromophenyl)-1-(1H-indol-3-yl) prop-2-en-1-one (IC9), also found predominant acetylcholinesterase inhibition and hence it was found dual acting in vitro. Based on this, the molecule IC9 was further subjected to cell line studies to further explore its role as a neuroprotective agent against neuronal degeneration, one of the main contributing parameters related to AD.

摘要

查耳酮(反式-1,3-二苯基-2-丙烯-1-酮)形成简单的化学结构,作为类黄酮生物合成的前体。这些存在于植物中,具有由三个碳原子的α、β-不饱和羰基连接的两个芳基或杂芳基环。鉴于查耳酮作为单胺氧化酶和乙酰胆碱酯酶抑制剂的重要性,本研究旨在进行全面系统的分析,以评估导致形成治疗阿尔茨海默病(AD)药物分子的药理活性。基于我们之前的研究,合成了 11 种吲哚基查耳酮(IC1-IC11),并研究了它们对 MAO-B 的抑制活性。根据使用纯化酶进行的结合和可逆性研究来评估抑制潜力。活性和最有前途的分子,(2E)-3-(4-溴苯基)-1-(1H-吲哚-3-基)丙-2-烯-1-酮(IC9),也发现具有明显的乙酰胆碱酯酶抑制作用,因此在体外具有双重作用。基于此,进一步对该分子 IC9 进行了细胞系研究,以进一步探索其作为神经保护剂对抗神经元变性的作用,神经元变性是与 AD 相关的主要参数之一。

相似文献

1
MAO-B Inhibitor (2E)-3-(4-Bromophenyl)-1-(1H-indol-3-yl) prop-2-en-1-one as a Neuroprotective Agent Against Alzheimer's Disease.MAO-B 抑制剂 (2E)-3-(4-溴苯基)-1-(1H-吲哚-3-基)丙-2-烯-1-酮作为一种治疗阿尔茨海默病的神经保护剂。
Neurochem Res. 2024 Jun;49(6):1518-1528. doi: 10.1007/s11064-023-04031-6. Epub 2023 Oct 9.
2
Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease.新型多奈哌齐-吲哚基杂合物作为多效胆碱酯酶/单胺氧化酶抑制剂用于潜在治疗阿尔茨海默病的设计、合成、药理学评价、定量构效关系分析、分子模拟及药物代谢动力学/药物毒性预测
Eur J Med Chem. 2014 Mar 21;75:82-95. doi: 10.1016/j.ejmech.2013.12.028. Epub 2014 Jan 27.
3
Design, synthesis and evaluation of chalcone Mannich base derivatives as multifunctional agents for the potential treatment of Alzheimer's disease.设计、合成并评价查尔酮曼尼希碱衍生物作为多功能药物用于潜在的阿尔茨海默病治疗。
Bioorg Chem. 2019 Jun;87:395-408. doi: 10.1016/j.bioorg.2019.03.043. Epub 2019 Mar 19.
4
Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease.设计、合成、计算机模拟及新型查尔酮-O-氨基甲酸酯衍生物的生物学评价——作为治疗阿尔茨海默病的多功能药物。
Eur J Med Chem. 2019 Sep 15;178:726-739. doi: 10.1016/j.ejmech.2019.06.026. Epub 2019 Jun 14.
5
Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.多奈哌齐和 N-[(5-(苄氧基)-1-甲基-1H-吲哚-2-基)甲基]-N-甲基丙-2-炔-1-胺杂合体的合成、生物评价和分子模拟作为治疗阿尔茨海默病的新型多效胆碱酯酶/单胺氧化酶抑制剂。
J Med Chem. 2011 Dec 22;54(24):8251-70. doi: 10.1021/jm200853t. Epub 2011 Nov 15.
6
Monoamine oxidase inhibitory activity of methoxy-substituted chalcones.甲氧基取代查耳酮的单胺氧化酶抑制活性。
Int J Biol Macromol. 2017 Nov;104(Pt A):1321-1329. doi: 10.1016/j.ijbiomac.2017.05.162. Epub 2017 Jun 1.
7
Morpholine-based chalcones as dual-acting monoamine oxidase-B and acetylcholinesterase inhibitors: synthesis and biochemical investigations.基于吗啉的查尔酮作为双重作用的单胺氧化酶-B 和乙酰胆碱酯酶抑制剂的研究:合成与生化研究。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):188-197. doi: 10.1080/14756366.2020.1842390.
8
Cholinesterase Inhibitory Activities of Selected Halogenated Thiophene Chalcones.所选卤代噻吩查耳酮的胆碱酯酶抑制活性
Cent Nerv Syst Agents Med Chem. 2019;19(1):67-71. doi: 10.2174/1871524918666181119114016.
9
4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease.4,6-二苯基嘧啶衍生物作为单胺氧化酶和乙酰胆碱酯酶的双重抑制剂用于治疗阿尔茨海默病。
ACS Chem Neurosci. 2019 Jan 16;10(1):252-265. doi: 10.1021/acschemneuro.8b00220. Epub 2018 Oct 22.
10
Selected 1,3-Benzodioxine-Containing Chalcones as Multipotent Oxidase and Acetylcholinesterase Inhibitors.含 1,3-苯并二氧杂环戊烯的查耳酮作为多功能氧化酶和乙酰胆碱酯酶抑制剂的研究。
ChemMedChem. 2020 Dec 3;15(23):2257-2263. doi: 10.1002/cmdc.202000491. Epub 2020 Oct 14.

本文引用的文献

1
Exploration of a new class of monoamine oxidase B inhibitors by assembling benzyloxy pharmacophore on halogenated chalcones.通过将苯氧基药效团组装在卤化查耳酮上来探索新型单胺氧化酶 B 抑制剂。
Chem Biol Drug Des. 2023 Aug;102(2):271-284. doi: 10.1111/cbdd.14238. Epub 2023 Apr 3.
2
An ongoing journey of chalcone analogues as single and multi-target ligands in the field of Alzheimer's disease: A review with structural aspects.查尔酮类似物作为阿尔茨海默病领域单靶点和多靶点配体的持续研究历程:基于结构方面的综述
Life Sci. 2023 May 1;320:121568. doi: 10.1016/j.lfs.2023.121568. Epub 2023 Mar 15.
3
Development of Isopropyl-Tailed Chalcones as a New Class of Selective MAO-B Inhibitors for the Treatment of Parkinson's Disorder.
异丙基尾型查尔酮作为一类新型选择性单胺氧化酶B抑制剂用于治疗帕金森病的研究进展
ACS Omega. 2023 Feb 7;8(7):6908-6917. doi: 10.1021/acsomega.2c07694. eCollection 2023 Feb 21.
4
Pathogenesis of Alzheimer's Disease.阿尔茨海默病的发病机制。
Int J Mol Sci. 2022 Dec 21;24(1):107. doi: 10.3390/ijms24010107.
5
Introduction of benzyloxy pharmacophore into aryl/heteroaryl chalcone motifs as a new class of monoamine oxidase B inhibitors.将苯甲氧基药效团引入芳基/杂芳基查尔酮母体中,作为单胺氧化酶 B 抑制剂的新类别。
Sci Rep. 2022 Dec 27;12(1):22404. doi: 10.1038/s41598-022-26929-x.
6
Development of Halogenated-Chalcones Bearing with Dimethoxy Phenyl Head as Monoamine Oxidase-B Inhibitors.含二甲氧基苯基的卤代查尔酮作为单胺氧化酶-B抑制剂的开发。
Pharmaceuticals (Basel). 2022 Sep 16;15(9):1152. doi: 10.3390/ph15091152.
7
Innate Immune Cell Death in Neuroinflammation and Alzheimer's Disease.固有免疫细胞死亡在神经炎症和阿尔茨海默病中的作用。
Cells. 2022 Jun 10;11(12):1885. doi: 10.3390/cells11121885.
8
Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials.阿尔茨海默病中的 Tau 生物标志物:迈向临床实践和试验的应用。
Lancet Neurol. 2022 Aug;21(8):726-734. doi: 10.1016/S1474-4422(22)00168-5. Epub 2022 May 25.
9
An updated patent review on monoamine oxidase (MAO) inhibitors.单胺氧化酶(MAO)抑制剂的最新专利研究综述。
Expert Opin Ther Pat. 2022 Aug;32(8):849-883. doi: 10.1080/13543776.2022.2083501. Epub 2022 Jun 9.
10
Design, synthesis, and evaluation of chalcone-Vitamin E-donepezil hybrids as multi-target-directed ligands for the treatment of Alzheimer's disease.查耳酮-维生素 E-多奈哌齐杂化物的设计、合成与评价:作为治疗阿尔茨海默病的多靶点定向配体。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):69-85. doi: 10.1080/14756366.2021.1993845.